Rising prevalence of chronic and acute disease is a key factor driving the global microRNA market, says Fortune Business Insights has published a premium research report on, titled, “MicroRNA Market Size, Share and Global Trend By Type (Product, Services miRNA cDNA Synthesis, miRNA Profiling & Purification, Next Generation Sequencing, Detection, miRNA Functional Studies, Micro Assays), By Application (Cancer, Cardiovascular Disease, Infectious Disease, Inherited Disease) By End User (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes) and Geography Forecast till 2026.” Rising demand for preventive care is expected to promote the growth of the global microRNA market.
list of key companies mentioned in microrna market report,
- Merck Sharp & Dohme Corp.
- Thermo Fisher Scientific
- Synlogic, Inc.
- GeneCopoeia, Inc.
- New England Biolabs
- Regulus Therapeutics Inc.
- NanoString Technologies, Inc.
- and BioGenex
- and other players.
According to the report, the rising adoption of advanced therapeutics for the treatment of cancer is expected to aid the expansion of the global microRNA. For instance, according to the American Cancer Society, In 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States and 609,640 people died from the disease. Approximately 38.4% of men and women were diagnosed with cancer at some point during their lifetimes.
Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/microrna-market-101237
The report provides a brief description of the microRNA industry while offering insights into the global microRNA market. The study also provides information regarding key industrial development and product launches.
Rising Awareness Regarding Microrna Therapeutics Will Enable Growth
The rising investments in research & development activities and is expected to support the growth of the global microRNA market. The increasing prevalence of chronic and acute diseases around the world is likely to boost the global microRNA market revenue during the forecast period. Furthermore, the unveiling of preclinical data in pulmonary fibrosis is expected to augment the growth of the global microRNA market.
For instance, miRagen Therapeutics presented preclinical data in pulmonary fibrosis with the usage of second-generation microRNA-29 replacement product candidate at the 2019 American Thoracic Society’s International Conference.
In addition, rising awareness regarding MicroRNA therapeutics along with increasing geriatric population is predicted to contribute significantly to the global microRNA market.
Increasing Demand for Preventive Care Will Boost Growth
The dynamic and transformative nature of MicroRNA therapeutics is likely to duel demand, which, will, in, turn aid growth of the global microRNA market. The rising demand for preventive care is also likely to enable growth of the global microRNA market.
Furthermore, the launch of RG-012 by Regulus Therapeutics Inc. is expected to escalate the global microRNA market shares. For instance, Regulus Therapeutics Inc. announced that their MicroRNA Therapeutic candidate called RG-012 for the Alport syndrome is on track as planned and was at the stage of initiation for Phase II clinical trials
Speak To Analyst : https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/microrna-market-101237
High Healthcare Expenditure Will Enable Growth in North America
The global MicroRNA market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America followed by Europe dominated the global MicroRNA market in 2018 and is expected to dominate during the forecast owing to the increasing investments in research & development, rising prevalence of acute & chronic diseases and established healthcare system.
In addition, high healthcare expenditure, and access to advanced technologies and rising demand for preventive medical care will further boost growth in the regions.
Asia Pacific is expected to grow at a remarkable rate owing to awareness of acute and chronic diseases, increasing access to advanced technologies, large patient pool, increasing geriatric population.
In addition, growing disposable incomes, rising awareness and demand for advanced diagnostic procedures and developing healthcare systems will further augment the growth in the region. MicroRNA market in Latin America and the Middle East and Africa is in the nascent stage; however, unmet needs for MicroRNA therapeutics is expected to drive the market in this region.
Browse Complete Report Details : https://www.fortunebusinessinsights.com/industry-reports/microrna-market-101237
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245